Related Experiment Video
Updated: Oct 23, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Pharmacogenomics variants are associated with BMI differences between individuals with bipolar and other psychiatric
Aggeliki Charalampidi1, Zoe Kordou1, Evangelia-Eirini Tsermpini1
1Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
Abstract:
Aim: Regardless of the plethora of next-generation sequencing studies in the field of pharmacogenomics (PGx), the potential effect of covariate variables on PGx response within deeply phenotyped cohorts remains unexplored. Materials & methods: We explored with advanced statistical methods the potential influence of BMI, as a covariate variable, on PGx response in a Greek cohort with psychiatric disorders. Results: Nine PGx variants within UGT1A6, SLC22A4, GSTP1, CYP4B1, CES1, SLC29A3 and DPYD were associated with altered BMI in different psychiatric disorder groups. Carriers of rs2070959 (UGT1A6), rs199861210 (SLC29A3) and rs2297595 (DPYD) were also characterized by significant changes in the mean BMI, depending on the presence of psychiatric disorders. Conclusion: Specific PGx variants are significantly associated with BMI in a Greek cohort with psychiatric disorders.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Related Concept Videos
Bipolar Disorder
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Mania and Antimanic Drugs: Overview
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Bulimia Nervosa
Antidepressant Drugs: MAOIs and Other Agents